AVP and ischemic stroke: Tu et al. (61) conducted a multicenter observational study of 4,125 patients, where they demonstrated that copeptin and NT-proBNP levels in patients with ischemic stroke can predict all-cause mortality and cardiovascular mortality at 1 year.